Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs
Related Experiment Video
Updated: Mar 5, 2026

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach
Published on: June 10, 2021
Fabrizio Carta1, Daniela Vullo2, Sameh M Osman3
1Università degli Studi di Firenze, Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Abstract:
SLC-0111 is a sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor (CAI) in Phase I/II clinical trials for the treatment of advanced hypoxic tumors complicated with metastases. Its antitumor effects are due to inhibition of the enzymatic activity of CA IX, an isoform predominantly found in tumors/metastases, but it also reduces the cancer stem cells population. Here we report the synthesis of analogs of SLC-0111, both of the sulfanilamide and metanilamide series, which possess diverse substitution patterns at the terminal ureido-phenyl moiety, thus including one or more halogens, trifluoromethyl, perchloro-/perfluorophenyl groups instead of the 4-fluorophenyl present in SLC-0111. Most of the sulfanilamide ureido derivatives were highly effective inhibitors of the tumor associated isoform and some showed selective CA IX/XII inhibitory profiles. Most of the sulfanilamide ureido derivatives were highly effective and in some cases selective CA IX/XII inhibitors, whereas the metanilamide ureido derivatives were less effective as transmembrane CA isoforms inhibitors. Structure activity relationship for this class of sulfonamides is discussed in detail.
Insights
New sulfonamide analogs of SLC-0111 effectively inhibit tumor-associated carbonic anhydrase IX (CA IX). Some analogs show selectivity for CA IX/XII, offering potential for advanced cancer treatments by targeting hypoxic tumors and cancer stem cells.
Area of Science:
- Medicinal Chemistry
- Oncology
- Biochemistry
Background:
- SLC-0111 is a carbonic anhydrase inhibitor (CAI) in clinical trials for advanced hypoxic tumors.
- CA IX is a tumor-associated isoform crucial for tumor growth and metastasis.
- CAI's antitumor effects include reducing cancer stem cells.
Purpose of the Study:
- Synthesize and evaluate novel SLC-0111 analogs.
- Investigate structure-activity relationships of new sulfonamide derivatives.
- Identify potent and selective inhibitors of carbonic anhydrase IX and XII.
Main Methods:
- Chemical synthesis of sulfanilamide and metanilamide analogs with varied substitutions.
- In vitro assessment of carbonic anhydrase inhibitory activity.
- Evaluation of selectivity profiles against CA IX and CA XII isoforms.
Main Results:
- Sulfanilamide analogs demonstrated high efficacy as CA IX inhibitors.
- Several sulfanilamide derivatives exhibited selective inhibition of CA IX/XII.
- Metanilamide analogs were less effective against transmembrane CA isoforms.
Conclusions:
- Novel sulfonamide derivatives show promise as targeted cancer therapeutics.
- Tailored substitutions can yield potent and selective CA IX/XII inhibitors.
- Structure-activity relationship analysis guides the development of next-generation CAIs.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Aldehydes and Ketones with HCN: Cyanohydrin Formation Overview
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Antihypertensive Drugs: Direct Renin Inhibitors
Preparation of Acid Anhydrides
The carboxylate ion acts as a nucleophile that attacks the carbonyl carbon of the acid chloride to form a tetrahedral intermediate. Subsequently, the re-formation of the carbonyl group with the loss of the chloride ion as a leaving group leads to the formation of an acid...

![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)